Zentalis Pharmaceuticals Announces Publication in the Journal of Medicinal Chemistry Highlighting the Discovery of its WEE1 Inhibitor Candidate ZN-c3

NEXT STORY
Brickell Biotech Expands Leadership Team, Appointing Dr. Monica Luchi as Chief Medical Officer
PREV STORY
MediciNova Announces MN-001 (tipelukast) Abstract regarding Lipid Metabolism in NASH/NAFLD Accepted for Presentation at The Liver Meeting® 2021, the Annual Meeting of the American Association for the Study of Liver Diseases
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Spero Therapeutics Announces Positive Topline Results from its Phase 3 ADAPT-PO Clinical Trial of Oral Tebipenem HBr in Complicated Urinary Tract Infection and Acute Pyelonephritis

author_avatar
NASDAQ Market News

Insights on the Immunohistochemistry Global Market to 2028 – Focus on Antibodies, Reagents and Kits

author_avatar
NASDAQ Market News

Next-generation Sequencing (NGS) Market – Growth, Trends, COVID-19 Impact, and Forecasts (2021 – 2026)

author_avatar
NASDAQ Market News